I wouldn't buy over .03,and I wouldn't hold through any reverse splits. Some of us understand the technology is a solution to the Achilles heel of the most commonly used battery chemistry on the market. The management of Axion has been short sighted in going after train and truck business that take years to prove itself instead of going after every day uses like UPS' and automobiles. If the Pbc ever gets into the consumer market, it could revolutionize the SLA battery and it's many uses. Unlike trains and trucks, the technology can be proven in the lab, and not on a rail yard, but the short sighted management didn't understand the true potential, and they wouldn't listen to me.
LCB has had samples for several months, and now have invited AXPW officials to come back for a renewal in marketing discussions. This could mean that they have tested the tech and have seen it's advantages and now want to cut a deal.
I don't see why LCB would be asking for more discussions if they weren't interested in the tech, or if the tech proved bad.
IOW, good news out of China changes everything. It's worth a couple large as a spec play. It will be especially worth it to see shorts like you loose you #$%$.
It seems like classic negotiation. Last year, LCB basically walked away from the table. Now Axion will be more desperate and more likely to cut a deal more favorable.
LCB has had time to thoroughly test the battery, and see the advantages, now they deal.
of course you did. I work with a guy who hits the perfect bottom and perfect top EVERY time, on EVERY trade. But yet, he doesn't quit his job and become a full time trader.
shorting at .02. That shows us he doesn't have anything in his sack or his head.
We'll see, won't we.
Expect results sometime in August, maybe even September. Those types of reports and results seem to always lag behind expectations, and the general concensus is almost always very optimistic.
They are desperate, and that is all that have. Let them act like fools, we'll laugh all the way to the bank.
It started out like a Beta, now I cannot turn it off, and I HATE IT
AC5 is far superior to Xcede. In just a few minutes of looking at their product, I can see numerous shortcomings when compared to AC5. The product has to be cut to size, which is time consuming. Xcede has adhesive on the back - #$%$ what happens if it isn't perfectly placed?. What about areas of the body that aren't flat, or are close to other structures? Compare that to squirting or spraying a liquid, and moving on with the procedure.
Sorry to be the bearer of bad news, but if you cannot understand why DYSL is a "sleeper" compared to ARTH, then you don't fully understand the products of the two companies. That's where DD comes into play.
it's pretty much a given that the warrants from May were exercised at .43. Imagine. 7M shares sold at .43
I wonder why. If they plan on selling the news and taking profit, which will create a pull back after news is released, or if they are expecting bad results and want to sell while they can.